secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lyra Therapeutics, Inc. (LYRA)
CIK:        0001327273
Form:       8-K
Filed at:   2023-09-01T23:59:59+00:00
Accession:  0001193125-23-227626
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lyra Therapeutics enters $50M at-the-market equity offering with Cantor Fitzgerald
--------------------------------------------------------------------------------

- Enters Controlled Equity Offering Sales Agreement to sell up to $50.0M of common stock through Cantor Fitzgerald.
- Shares sold in at-the-market offerings; Cantor receives 3.0% commission on gross proceeds.
- Company has no obligation to sell any shares and may suspend or terminate offering at any time.
- Offering registered under existing S-3 shelf; prospectus supplement filed September 1, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1327273/000119312523227626/0001193125-23-227626-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1327273/000119312523227626/d498636d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-227626

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer